Hangzhou Converd Co., Ltd.

This study tests a new treatment called hV01, a virus modified to attack cancer cells and boost the immune system. It is for 12 people with advanced pancreatic cancer that has not responded to standard treatments. The goal is to see if the virus can shrink tumors and control the …

This study tests a new treatment for people with advanced solid tumors that have not responded to standard therapies. The treatment combines a modified virus (hV01) that targets and kills cancer cells while boosting the immune system, with an immunotherapy drug (tislelizumab) tha…